Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
    • CHEST 2021
    • IDWeek 2021
    • IAS 2021
    • ADA 2021
    • ATS 2021
    • ACC 2021
    • ACP 2021
    • AAN 2021
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
    • CHEST 2021
    • IDWeek 2021
    • IAS 2021
    • ADA 2021
    • ATS 2021
    • ACC 2021
    • ACP 2021
    • AAN 2021

Table of Contents

November 01, 2001; Volume 68,Issue 11

From the Editor

  • You have access
    COX-2 inhibitors: Balancing the hope, the hype, and the concern
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine November 2001, 68 (11) 899;

    When all is said and done, the choice rests with the individual prescribing physician.

Medical Grand Rounds

  • You have access
    Management of primary headache: Serendipity and science
    Glen D. Solomon, MD
    Cleveland Clinic Journal of Medicine November 2001, 68 (11) 904-912;

    A capsule summary of the current management of migraine, chronic tension headache, and cluster headache.

  • You have access
    Chronic myelogenous leukemia: The news you have and haven’t heard
    Matt E. Kalaycio, MD
    Cleveland Clinic Journal of Medicine November 2001, 68 (11) 913-926;

    One major advance in treating CML was widely publicized. Another, although equally important, was not.

Review

  • You have access
    Recognizing and treating diabetic autonomic neuropathy
    Aaron I. Vinik, MD, PhD and Tomris Eras, MD
    Cleveland Clinic Journal of Medicine November 2001, 68 (11) 928-944;

    Strict glycemic control can slow the onset of diabetic autonomic neuropathy and sometimes reverse it. Other treatments address specific symptoms.

  • You have access
    Role of alendronate and risedronate in preventing and treating osteoporosis
    Margaret L. Peters, PharmD, Mandy Leonard, PharmD and Angelo A. Licata, MD, PhD
    Cleveland Clinic Journal of Medicine November 2001, 68 (11) 945-951;

    A review of the efficacy and use of the two oral bisphosphonates approved for preventing and treating osteoporosis.

The Clinical Picture

  • You have access
    A 44-year-old man with a pruritic skin rash
    Raed Bargout, MD and Amit Malhotra, MD
    Cleveland Clinic Journal of Medicine November 2001, 68 (11) 952-953;

    Questions and answers on the visible signs of diseases.

1-Minute Consult

  • How often are atrial septal defects associated with thromboembolism? When should they be looked for?
    You have access
    How often are atrial septal defects associated with thromboembolism? When should they be looked for?
    Wael A. Jaber, MD and Allan L. Klein, MD
    Cleveland Clinic Journal of Medicine November 2001, 68 (11) 954-956;

    In the absence of other causative conditions, an atrial septal defect may be presumed to be the underlying cause of a stroke, especially in younger patients.

Editorial

  • You have access
    Cox - 2 Inhibitors and Cardiovascular Risk
    Brian F. Mandell, MD, PHD
    Cleveland Clinic Journal of Medicine November 2001, 68 (11) 957-959;

    Even if we do not know with certainty whether COX-2 inhibitors increase the risk of cardiovascular events, we need to incorporate this concern into our practice.

Point and Counterpoint

  • You have access
    Cox - 2 Inhibitors and Cardiovascular Risk
    John Lipani, MD
    Cleveland Clinic Journal of Medicine November 2001, 68 (11) 961-962;

    Unless a clear cause-and-effect relationship can be proved between COX-2 inhibitors and cardiovascular events, we should go on using these drugs.

  • You have access
    Cox - 2 Inhibitors and Cardiovascular Risk
    Debabrata Mukherjee, MD, Steven E. Nissen, MD and Eric J. Topol, MD
    Cleveland Clinic Journal of Medicine November 2001, 68 (11) 963-964;

    Our study had limitations, but we believe our hypothesis is plausible, our methods were valid, and our conclusions are sound.

Back to top
PreviousNext

In this issue

Cleveland Clinic Journal of Medicine: 68 (11)
Cleveland Clinic Journal of Medicine
Vol. 68, Issue 11
1 Nov 2001
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
Sign up for alerts

Jump to

  • From the Editor
  • Medical Grand Rounds
  • Review
  • The Clinical Picture
  • 1-Minute Consult
  • Editorial
  • Point and Counterpoint
  • Editor's Picks
  • Most Cited
  • Most Read
Loading
Oral leukoplakia and oral cancer
A 50-year-old man presents with shortness of breath
Myasthenia gravis: Frequently asked questions
Central vision loss in a 44-year-old woman
Median rhomboid glossitis caused by tongue-brushing
Making best use of bone turnover markers to monitor oral bisphosphonate therapy
Asymptomatic granules on the buccal mucosa
Does my patient need to be screened or treated for a urinary tract infection?
Ignore e-cigarettes at your patient’s peril
Spontaneous oral hematoma diagnosed as angina bullosa hemorrhagica
Hypophosphatemia in a patient with an eating disorder
Scaly plaques in a malnourished patient
Confusion in a 22-year-old woman, and diagnostic uncertainty
How do we maximize diuresis in acute decompensated heart failure?

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2023 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire